Protalix BioTherapeutics
PLX
#8648
Rank
HK$0.63 B
Marketcap
HK$8.57
Share price
-4.35%
Change (1 day)
-35.89%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -HK$0.11 B

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -HK$0.11 B. In 2023 the company made an earning of HK$91.62 M an increase over its 2022 earnings that were of -HK$92.51 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.11 B-212.28%
2023 HK$91.62 M-199.05%
2022 -HK$92.51 M-40.38%
2021 -HK$0.16 B-732.31%
2020 HK$24.53 M-130.53%
2019 -HK$80.37 M189.85%
2018 -HK$27.73 M-95.29%
2017 -HK$0.59 B308.12%
2016 -HK$0.15 B-32.37%
2015 -HK$0.22 B10.11%
2014 -HK$0.2 B-7.59%
2013 -HK$0.21 B
2011 -HK$0.25 B-19.39%
2010 -HK$0.31 B20.87%
2009 -HK$0.25 B32.26%
2008 -HK$0.19 B-5.46%
2007 -HK$0.2 B
2004 -HK$1.3 M12.35%
2003 -HK$1.15 M-11.1%
2002 -HK$1.3 M-57.03%
2001 -HK$3.01 M1.03%
2000 -HK$2.98 M-53.22%
1999 -HK$6.37 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.78 B 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.89 B-3,895.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.45 B 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.44 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel